Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Stocks to Buy Now for Passive Income.  Why Bristol-Myers Squibb (BMY) Deserves a Spot in Passive Income Portfolios Bristol-Myers Squibb Company (NYSE:BMY) is a global biopharmaceutical company that many consider worth investing in and holding long-term. Its history dates back to the early 1800s, shaped by decades of drug innovation and strategic mergers. Today, the company focuses on treatments in oncology, cardiovascular health, immun ...

文章核心观点 - 免疫疗法供应商艾伯维公司股价上涨1.7%，投资者对此满意，且今日收盘时涨幅可能更高 [1] 行业相关 - 宏观经济学家Manika有超20年投资管理、股票经纪、投资银行等行业经验，运营专注绿色经济长期机会的Long Term Tips [LTT] ，其投资组织Green Growth Giants 进一步深入挖掘该领域机会 [1]